Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
AIDS Wasting in Women: Anabolic Effects of Testosterone
This study has been completed.
Study NCT00006158 Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First Received on August 8, 2000. Last Updated on February 12, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
AIDS Wasting Syndrome
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
HIV Wasting Syndrome
Wasting Syndrome
More general conditions related to this trial
HIV Infections
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Metabolic Diseases
Nutrition Disorders
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Testosterone
Additional drug interventions recognized in this trial
Methyltestosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate
More general drug interventions related to this trial
Anabolic Agents
Androgens
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Back to top of Main Content
